Immune mechanisms underlying host susceptibility to infection with group A streptococci

Journal of Infectious Diseases

Volumn 187, Issue 5, 2003, Pages 854-861

  Goldmann, Oliver ^a   Chhatwal, Gursharan Singh ^a   Medina, Eva ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DEATH; FEMALE; HOST RESISTANCE; HOST SUSCEPTIBILITY; IMMUNITY; IN VITRO STUDY; INFECTION CONTROL; INFLAMMATION; MOUSE; MOUSE STRAIN; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SPLEEN CELL; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; TISSUE INJURY;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; INFLAMMATION; LIVER; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; SPLEEN; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 0037333936     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/368390     Document Type: Article

References (41)

1. Efstratiou A. Group A streptococci in the 1990s. J Antimicrob Chemother 2000; 45 Suppl:13-12.
2. Gaworzewska E, Colman G. Changes in the pattern of infection caused by Streptococcus pyogenes. Epidemiol Infect 1988; 100:257-69.
3. Schwartz B, Facklam RR, Breiman RF. Changing epidemiology of group A streptococcal infection in the USA. Lancet 1990; 336:1167-71.
4. Cone LA, Woodard DR, Schlievert PM, Tomory GS. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med 1987; 317:146-9.
5. Stevens DL, Tanner MH, Winship J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989; 321:1-7.
6. Davies HD, McGeer A, Schwartz B, et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med 1996; 335:547-54.
7. Eriksson BK, Andersson J, Holm SE, Norgren M. Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome. Clin Infect Dis 1998; 27:1428-36.
8. Cleary PP, Kaplan EL, Handley JP, et al. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet 1992; 339:518-21.
9. Martin DR, Single LA. Molecular epidemiology of group A streptococcus M type 1 infections. J Infect Dis 1993; 167:1112-7.
10. Musser JM, Kapur V, Szeto J, Pan X, Swanson DS, Martin DR. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease. Infect Immun 1995; 63:994-1003.
11. Kiska DL, Thiede B, Caracciolo J, et al. Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. J Infect Dis 1997; 176:992-1000.
12. Inagaki Y, Konda T, Murayama S, et al. Serotyping of Streptococcus pyogenes isolated from common and severe invasive infections in Japan, 1990-5: implication of the T3 serotype strain-expansion in TSLS. The Working Group for Group A Streptococci in Japan. Epidemiol Infect 1997; 119:41-8.
13. Muotiala A, Seppala H, Huovinen P, Vuopio-Varkila J. Molecular comparison of group A streptococci of T1M1 serotype from invasive and noninvasive infections in Finland. J Infect Dis 1997; 175:392-9.
14. Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome: a retrospective population-based study. JAMA 1993; 269:384-9.
15. Musser JM, Kapur V, Kanjilal S, et al. Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (Scarlet fever toxin). J Infect Dis 1993; 167:337-46.
16. Cockerill FR 3rd, MacDonald KL, Thompson RL, et al. An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA 1997; 277:38-43.
17. Norgren M, Norrby A, Holm SE. Genetic diversity in T1M1 group A streptococci in relation to clinical outcome of infection. J Infect Dis 1992; 166:1014-20.
18. Chatellier S, Ihendyane N, Kansal RG, et al. Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun 2000; 68:3523-34.
19. Haukness HA, Tanz RR, Thomson RB Jr, et al. The heterogeneity of endemic community pediatric group a streptococcal pharyngealisolates and their relationship to invasive isolates. J Infect Dis 2002; 185:915-20.
20. Sharkawy A, Low DE, Saginur R, et al. Severe group a streptococcal soft-tissue infections in Ontario: 1992-1996. Clin Infect Dis 2002; 34:454-60.
21. Norrby-Teglund A, Chatellier S, Low DE, McGeer A, Green K, Kotb M. Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection. Eur J Immunol 2000; 30:3247-55.
22. Norrby-Teglund A, Lustig R, Kotb M. Differential induction of Th1 versus Th2 cytokines by group A streptococcal toxic shock syndrome isolates. Infect Immun 1997; 65:5209-15.
23. Norrby-Teglund A, Norgren M, Holm SE, Andersson U, Andersson J. Similar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B. Infect Immun 1994; 62:3731-8.
24. Medina E, Goldmann O, Rohde M, Lengeling A, Chhatwal GS. Genetic control of susceptibility to group A streptococcal infection in mice. J Infect Dis 2001; 184:846-52.
25. Reed LJ, Muench H. A simple method for estimating fifty percent end points. Am J Hyg 1938; 27:493-7.
26. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 1982; 126:131-8.
27. Wong JM, Billiar TR. Regulation and function of inducible nitric oxide synthase during sepsis and acute inflammation. Adv Pharmacol 1995; 34:155-70.
28. Bhakdi S, Klonisch T, Nuber P, Fischer W. Stimulation of monokine production by lipoteichoic acids. Infect Immun 1991; 59:4614-20.
29. Keller R, Fischer W, Keist R, Bassetti S. Macrophage response to bacteria: induction of marked secretory and cellular activities by lipoteichoic acids. Infect Immun 1992; 60:3664-72.
30. McCormick JK, Yarwood JM, Schlievert PM. Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol 2001; 55:77-104.
31. Ring A, Stremmel W. The hepatic microvascular responses to sepsis. Semin Thromb Hemost 2000; 26:589-594.
32. Tombaugh GC, Sapolsky RM. Evolving concepts about the role of acidosis in ischemic neuropathology. J Neurochem 1993; 61:793-803.
33. Gallin JI, Goldstein IM, Snyderman R. Inflammation: Basic principles and clinical correlates. 2nd ed. Lippincott-Raven, Philadelphia, 1992:342-51.
34. Dinarello CA. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 1997; 112:321S-329S.
35. Cavaillon JM, Muller-Alouf H, Alouf JE. Cytokines in streptococcal infections: an opening lecture. Adv Exp Med Biol 1997; 418:869-79
36. Norrby-Teglund A, Pauksens K, Norgren M, Holm SE. Correlation between serum TNF alpha and IL6 levels and severity of group A streptococcal infections. Scand J Infect Dis 1995; 27:125-30.
37. Fang FC. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 1997; 99:2818-25.
38. Thiemermann C. Nitric oxide and septic shock. Gen Pharmacol 1997; 29:159-66.
39. Lonchampt MO, Auguet M, Delaflotte S, Goulin-Schulz J, Chabrier PE, Braquet P. Lipoteichoic acid: a new inducer of nitric oxide synthase. J Cardiovasc Pharmacol 1992; 20 Suppl 12:S145-7.
40. Ginsburg I. Role of lipoteichoic acid in infection and inflammation. Lancet Infect Dis 2002; 2:171-9.
41. Nuijens JH, Abbink JJ, Wachtfogel YT, et al. Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis. J Lab Clin Med 1992; 119:159-68.